Combined bottle and cap
Latest Bristol-Myers Squibb Company Patents:
- Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors
- Antibodies Binding to Human PAD4 and Uses Thereof
- Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment
- Substituted bicyclic compounds useful as T cell activators
- METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR
Description
FIG. 1 is a perspective view of our new design of a combined bottle and cap;
FIG. 2 is a top plan view thereof;
FIG. 3 is a front elevation view thereof;
FIG. 4 is a side elevational view thereof, the undisclosed opposite side being a mirror image;
FIG. 5 is a rear elevational view thereof; and,
FIG. 6 is a bottom plan view thereof.
Referenced Cited
Patent History
Patent number: D403592
Type: Grant
Filed: Jul 14, 1997
Date of Patent: Jan 5, 1999
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventors: Joseph M. Everard (Fairfield, CT), Sara Hendelman-Schorer (New York, NY)
Primary Examiner: Lucy Lieberman
Attorney: Anthony M. Santini
Application Number: 0/73,532
Type: Grant
Filed: Jul 14, 1997
Date of Patent: Jan 5, 1999
Assignee: Bristol-Myers Squibb Company (New York, NY)
Inventors: Joseph M. Everard (Fairfield, CT), Sara Hendelman-Schorer (New York, NY)
Primary Examiner: Lucy Lieberman
Attorney: Anthony M. Santini
Application Number: 0/73,532
Classifications
Current U.S. Class:
D/9542;
D9/449
International Classification: 0901;
International Classification: 0901;